| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| intoxication par le tamoxifène d'intention indéterminée |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Formestane poisoning (disorder) |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Accidental formestane poisoning |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intentional formestane poisoning (disorder) |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| intoxication par le formestane d'intention indéterminée |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Vinca alkaloid poisoning |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Vinblastine poisoning |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Accidental vinblastine poisoning (disorder) |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intentional vinblastine poisoning |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| intoxication par la vinblastine d'intention indéterminée |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Vincristine poisoning |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Accidental vincristine poisoning |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intentional vincristine poisoning |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| intoxication par la vincristine d'intention indéterminée |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Vindesine poisoning |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Accidental vindesine poisoning |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intentional vindesine poisoning |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| intoxication par la vindésine d'intention indéterminée |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Immunosuppressant poisoning |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Cyclosporin poisoning |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Accidental cyclosporin poisoning |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intentional cyclosporin poisoning |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cyclosporin poisoning of undetermined intent |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Immunosuppressant adverse reaction |
Causative agent (attribute) |
True |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Cyclosporin adverse reaction (disorder) |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Immunosuppressant allergy |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Allergy to ciclosporin (finding) |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Immunosuppressant overdose |
Causative agent (attribute) |
True |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Cyclosporin overdose |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Accidental cyclosporin overdose |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intentional cyclosporin overdose |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cyclosporin overdose of undetermined intent |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Poisoning by thio-TEPA (disorder) |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Abciximab 10mg/5mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Poisoning by fluorouracil |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Palivizumab 50mg injection (pdr for recon)+solvent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Drugs used in malignant disease and for immunosuppression |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cytotoxic immunosuppressants |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Antilymphocyte immunoglobulin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Rituximab 10mg/mL injection concentrate 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Rituximab 10mg/mL infusion concentrate 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Human monoclonal IgM antibody (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| HA-1A |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Equine anti-human thymocyte immunoglobulin 100mg/5mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Equine gamma globulin 10mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Mouse monoclonal antibody |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Rabbit anti-human T-lymphocyte globulin (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Rabbit anti-human T-lymphocyte globulin 25mg powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Abciximab 10mg/5 mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cyclosporine 250mg/amp |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cyclosporine 100mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Palivizumab 100mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cyclosporine 250mg/5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cyclosporine 100mg/5mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cyclosporine 25mg gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cyclosporine 100mg gel capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cyclosporine 50mg gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Rituximab 500mg infusion concentrate vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Rituximab 100mg infusion concentrate vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing gemtuzumab ozogamicin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tacrolimus |
Is a |
True |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Mycophenolate mofetil (substance) |
Is a |
True |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sirolimus (substance) |
Is a |
True |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing anakinra (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Anakinra 100mg/0.67mL injection prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Poisoning caused by antineoplastic antibiotic |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Poisoning caused by bleomycin (disorder) |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Poisoning by cactinomycin |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lymphocyte immunoglobulin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| médicament immunosuppresseur |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Poisoning caused by cyclophosphamide (disorder) |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing ciclosporin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Poisoning by mercaptopurine |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Poisoning by chlorambucil |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ciclosporin (substance) |
Is a |
True |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Alefacept (substance) |
Is a |
True |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing adalimumab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Palivizumab 100mg powder for injection 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tositumomab-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing omalizumab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing efalizumab (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Raptiva |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Efalizumab 125mg/vial lyophilized powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Raptiva 125mg/vial lyophilized powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Anakinra 100mg/0.67mL injection prefilled syringe (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Mycophenolic acid (substance) |
Is a |
True |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Gemtuzumab ozogamicin (substance) |
Is a |
True |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Omalizumab |
Is a |
True |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Efalizumab (substance) |
Is a |
True |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Rituximab (substance) |
Is a |
True |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Antilymphocyte immunoglobulin - chemical (substance) |
Is a |
True |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Rabbit anti-human T-lymphocyte globulin |
Is a |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tositumomab 14mg/mL/Iodine 131 5.6mCi/mL/Tositumomab 1.1mg/mL injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Substance with selective adhesion molecule inhibitor mechanism of action (substance) |
Is a |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Substance with calcineurin inhibitor mechanism of action (substance) |
Is a |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Muromonab-CD3 (substance) |
Is a |
True |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ibritumomab tiuxetan (substance) |
Is a |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Macrolide immunosuppressant |
Is a |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| [X]Immunosuppressive agents causing adverse effects in therapeutic use |
Causative agent (attribute) |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Adalimunab 40mg/mL injection solution 1mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immunosuppressant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]